203 related articles for article (PubMed ID: 7510150)
1. Effects of prostaglandin of E, F and I series, leukotriene C and platelet activating factor on amylase release from isolated rat pancreatic acini.
Jaworek J; Konturek SJ
J Physiol Pharmacol; 1993 Dec; 44(4):365-81. PubMed ID: 7510150
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 inhibits secretagogue-induced enzyme secretion from rat pancreatic acini.
Mössner J; Secknus R; Spiekermann GM; Sommer C; Biernat M; Bahnsen H; Fischbach W
Am J Physiol; 1991 May; 260(5 Pt 1):G711-9. PubMed ID: 1709788
[TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
[TBL] [Abstract][Full Text] [Related]
4. The effects of ammonia on pancreatic enzyme secretion in vivo and in vitro.
Jaworek J; Bilski J; Jachimczak B; Cieszkowski M; Kot M; Bielański W; Konturek SJ
J Physiol Pharmacol; 2000 Jun; 51(2):315-32. PubMed ID: 10898103
[TBL] [Abstract][Full Text] [Related]
5. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
[TBL] [Abstract][Full Text] [Related]
6. Effect of secretin and caerulein in canine pancreas: relation to prostaglandins.
Homma T; Malik KU
Am J Physiol; 1983 Jun; 244(6):G660-7. PubMed ID: 6344655
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of arachidonic acid by pancreatic acini: relation to amylase secretion.
Stenson WF; Lobos E
Am J Physiol; 1982 May; 242(5):G493-7. PubMed ID: 6177254
[TBL] [Abstract][Full Text] [Related]
8. Effects of pirenzepine and atropine on amylase response to various secretagogues from the rat pancreatic acini.
Jaworek J; Konturek SJ
Digestion; 1987; 36(3):175-81. PubMed ID: 2439400
[TBL] [Abstract][Full Text] [Related]
9. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
[TBL] [Abstract][Full Text] [Related]
11. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
Campbell WB; Gomez-Sanchez CE
Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
[TBL] [Abstract][Full Text] [Related]
12. Effects of exogenous prostaglandins on the release of leukotriene C4-like immunoreactivity and on coronary flow in indomethacin-treated anaphylactic guinea-pig hearts.
Aehringhaus U; Dembinska-Kiéc A; Peskar BA
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):368-74. PubMed ID: 6384796
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differences.
Linari G; Improta G; Agostini S; Andreassi A; Broccardo M
Peptides; 2004 Jan; 25(1):45-51. PubMed ID: 15003355
[TBL] [Abstract][Full Text] [Related]
14. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
16. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.
Konturek SJ; Dembinski A; Konturek PJ; Warzecha Z; Jaworek J; Gustaw P; Tomaszewska R; Stachura J
Gut; 1992 Sep; 33(9):1268-74. PubMed ID: 1385272
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue.
Nishiyama R; Nakamura S; Suzuki S; Baba S
Transplantation; 1993 Jun; 55(6):1261-5. PubMed ID: 8516812
[TBL] [Abstract][Full Text] [Related]
18. Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet-activating factor.
Hsueh W; Gonzalez-Crussi F; Arroyave JL
J Clin Invest; 1986 Jul; 78(1):108-14. PubMed ID: 3459734
[TBL] [Abstract][Full Text] [Related]
19. A novel enhancing effect of platelet activating factor (PAF) on glucose oxidation in uteri from pregnant rats. Participation of prostaglandins and leukotrienes.
González E; Gimeno AL; Gimeno MA
Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):79-84. PubMed ID: 2399270
[TBL] [Abstract][Full Text] [Related]
20. Effects of peptide YY on dog and rat pancreatic secretion in vivo and in vitro.
Bilski J; Hladij M; Jaworek J; Konturek SJ; Varga G
Int J Pancreatol; 1988 Jul; 3(5):309-21. PubMed ID: 2459272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
